Avascular necrosis prevention with lipitor in lupus erythematosus [2]

Lupus

Volumn 14, Issue 10, 2005, Pages 869-870

  Belmont, H Michael ^a   Lydon, E ^a  

^a NYU HOSPITAL FOR JOINT DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; C REACTIVE PROTEIN; CHOLESTEROL; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CREATINE KINASE; DOUBLE STRANDED DNA; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID ANTIBODY; STEROID; TRIACYLGLYCEROL;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; AVASCULAR NECROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DRUG EFFECT; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; LETTER; LIVER TOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTICHOLESTEREMIC AGENTS; DOUBLE-BLIND METHOD; HEPTANOIC ACIDS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; OSTEONECROSIS; PYRROLES;

EID: 27744580314     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203305lu2189xx     Document Type: Letter

References (7)

1. Wang GJ, Rawles JG, Hubbard S, Stamp W. Steroid-induced femoral head pressure changes and their response to lipid-clearing agents. Clin Orthop Related Res 1983; 174: 298-302.
2. Asherson RA, Liote F, Page B et al. Avascular necrosis of bone and antiphospholipid antibodies and systemic lupus erythematosus. J Rheumatol 1995; 20: 284-288.
3. Nagasawa K, Tada Y, Koarada S et al. Very early development of steroid-associated osteonecrosis of femoral head in systemic lupus erythematosus: prospective study by MRI. Lupus 2005; 14: 385-390.
4. Vande Berg VC, Malghem J, Lecouvet FE, Devogelaer JP, Maldague B, Houssiau FA. Fat conversion of femoral marrow in glucocorticoid-treated patients. Arthritis and Rheumatism 1999; 42: 1405-1411.
5. Vaughan CJ, Murphy MB, Buckley BM. Statins do more than just lower cholesterol. Lancet 1996; 348: 1079-1082.
6. Belmont HM, Lydon E, Rafii M, Schweitzer M. Prevention of avascular necrosis of bone in systemic lupus erythematosus APLLE trial. Arthritis and Rheumatism 2004; 50: S597-598 (abstract 1579).
7. Oinuma K, Harada Y, Nawata Y et al. Osteonecrosis in patients with SLE develops very early after starting high dose steroid treatment. Ann Rheum Dis 2001; 60: 1145.